Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 60 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Georgianos, Panagiotis I [Clear All Filters]
Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials..
Hypertens Res. 41(5), 309-319.
(2018). Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring..
Am J Nephrol. 47(1), 21-29.
(2018). Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed..
J Am Soc Hypertens. 12(4), 242-247.
(2018). Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report..
BMC Nephrol. 19(1), 293.
(2018). Blood pressure and target-organ damage in hemodialysis: but which blood pressure?.
J Hypertens. 35(12), 2552-2553.
(2017). Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease..
Int Urol Nephrol. 49(12), 2217-2221.
(2017). Exploring the association of arterial stiffness with estimated glomerular filtration rate: another chicken-egg paradigm?.
J Hypertens. 35(3), 650-651.
(2017). Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence..
Curr Vasc Pharmacol. 15(6), 599-606.
(2017). Echocardiographic Parameters During Long and Short Interdialytic Intervals in Hemodialysis Patients..
Am J Kidney Dis. 68(5), 772-781.
(2016). Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis..
Int Urol Nephrol. 48(4), 601-8.
(2016). Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues..
J Clin Hypertens (Greenwich). 18(3), 197-9.
(2016). Advances in treatment of hyperkalemia in chronic kidney disease..
Expert Opin Pharmacother. 16(14), 2205-15.
(2015). Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?.
Am J Nephrol. 41(4-5), 400-8.
(2015). Ambulatory aortic blood pressure, wave reflections and pulse wave velocity are elevated during the third in comparison to the second interdialytic day of the long interval in chronic haemodialysis patients..
Nephrol Dial Transplant. 30(12), 2046-53.
(2015). Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis..
Clin J Am Soc Nephrol. 10(4), 630-8.
(2015). Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?.
Am J Hypertens. 28(8), 958-65.
(2015). Opponent's comment..
Nephrol Dial Transplant. 30(1), 27-8.
(2015). Pro: Should we move to more frequent haemodialysis schedules?.
Nephrol Dial Transplant. 30(1), 18-22.
(2015). Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population..
Semin Nephrol. 34(5), 483-91.
(2014). Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients..
Am J Nephrol. 40(3), 242-50.
(2014). Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures..
Blood Purif. 37(1), 18-26.
(2014). Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness..
J Clin Hypertens (Greenwich). 16(7), 475-6.
(2014). Arterial Stiffness: a Novel Cardiovascular Risk Factor in Kidney Disease Patients..
Curr Vasc Pharmacol.
(2013). Diverse effects of interdialytic intervals on central wave augmentation in haemodialysis patients..
Nephrol Dial Transplant. 28(8), 2160-9.
(2013).
(2013).